Medical
Mesothelioma Clinical Trial Pipeline 2026: 30+ Studies Reshaping Treatment After Nivolumab
David Foster
March 17, 2026
The 2026 mesothelioma clinical trial pipeline features 30+ active studies in CAR-T therapy, EZH2 inhibitors, ADCs, cancer vaccines, and proton beam therapy — offering new options for patients beyond nivolumab.
13 min read 6 FAQs
Read